Posts

STAT+: Omada tackles obesity drugs, Boston Scientific n...

In the latest edition of STAT's Health Tech newsletter: Omada tackles obesity dr...

STAT+: Will Medicare cover it? Drugs like Aduhelm are c...

Medicare’s coverage decision has revived longstanding questions about how the fe...

Robot centipedes go for a walk

Osaka, Japan – Researchers from the Department of Mechanical Science and Bioengi...

Super low-cost smartphone attachment brings blood press...

Engineers at the University of California San Diego have developed a simple, low...

KRISS ushers in era of green hydrogen

Hydrogen has been gaining attention as a clean and efficient energy source. Howe...

Pan-cancer T cell atlas reveals new details of tumor mi...

HOUSTON ― A new study led by researchers at The University of Texas MD Anderson ...

A novel blood serum assay to diagnose neurodegenerative...

Synucleinopathies are a group of neurodegenerative diseases caused by the abnorm...

Vehicle stop study illuminates importance of officer’s ...

Eugenia Rho believes in the importance of first impressions, especially during v...

Mapping the conflict between farming and biodiversity

Food is one of society’s great moral quandaries. Its production pushes many spec...

Who’s acquiring who? Virtual care M&A activity in the p...

Analysis of the key themes driving M&A activity reveals that virtual care accoun...

Who’s acquiring who? Immuno-oncology M&A activity in th...

Analysis of the key themes driving M&A activity reveals that immuno-oncology acc...

Who’s acquiring who? Orphan designated drugs M&A activi...

Analysis of the key themes driving M&A activity reveals that orphan designated d...

STAT+: Neuralink can now study its brain implant in hum...

Neuralink, however closely watched, is still catching up to its peers in the neu...

Omada tackles obesity drugs, Boston Scientific nixes de...

In the latest edition of STAT's Health Tech newsletter: Omada tackles obesity dr...

Some hoped a new oral vaccine would solve all the polio...

Millions of doses into the rollout of a new polio vaccine, it is apparent that t...

STAT+: Pharmalittle: EMA urges revoking authorization f...

The European Medicines Agency recommended revoking marketing authorization for a...